Option 1: CHF 449 per share for 66.7% of the common stock + the remaining equity remaining publicly
Option 2: CHF 449 per share for 100% of the common stock with all cash
Implication
Monsanto dropped out and Syngenta started considering equity investment from ChemChina
December 3, 2015
Offer
Option 1: CHF 460 per share for 66.7% of its common shares, maintaining Syngenta's listed status
Option 2: CHF 449 per share for an unchanged all-cash offer for 100% of the company
Adjustment
Option 1: A US$5 per share increase to acquire 66.7% of the ordinary shares, but eliminated the option to sell the remaining ordinary shares
Option 2: A US$11 per share increase to acquire 100% of the company
December 15, 2015
Offer
A increase of $5 per share for both the 66.7% and 100% options, reaching CHF 470 and CHF 465 per share, respectively
An additional dividend of CHF 5 per share would be given to Syngenta shareholders after the acquisition
Followup
Terms of the offer, financing commitments, commitment to obtain administrative approvals and corporate governance arrangements
February 2, 2016
Deal
100% of Syngenta's equity at US$465/share and US$93/ADS, with a special dividend payment of US$5(US/CHF exchange rate:1.00)